Urban Supreme System

A few days ago, Joint Spirit has been approved by multiple countries.

And because Li Changhua has already prepared all the work, once the approval is passed, it will be ready to be officially put on the market and begin to be tested by patients.

Although Joint Spirit is not sold all over the world at the same time, the population of the selected countries can be ranked high, so the sales volume of Joint Spirit will not be low.

Regarding the drug Joint Spirit, Changhua Pharmaceutical has not done any publicity for it in China.

Just a few days ago, Li Changhua held a new drug press conference and announced that Joint Spirit had passed human clinical trials and had been approved by the Food and Drug Administration.

Apart from this, Changhua Pharmaceutical has not done any other publicity for Joint Ling, nor has it invited celebrities to shoot commercials.

However, because the drugs that Changhua Pharmaceutical has successively launched before are all heavyweight drugs, they have had a huge impact on the drug market and changed the original static situation.

Therefore, the influence and popularity of Changhua Pharmaceutical are already high, and media from all over the country are paying attention to Changhua Pharmaceutical at any time.

Now that Changhua Pharmaceutical is about to launch a new drug, these media will take the initiative to report on it, which is much better than advertising.

Of course, this is not completely without disadvantages. As long as there is any negative news about Changhua Pharmaceutical or any problems with Joint Spirit, these media will report it mercilessly.

Because these media just want attractive news, and Changhua Pharmaceutical itself is big news, and there are many patients now. Or their family members are very concerned about Changhua Pharmaceutical. I hope Changhua Pharmaceutical can launch more useful drugs.

It is exactly what so many people are looking forward to and paying attention to. That’s why media across the country rush to report the news about Changhua Pharmaceutical.

Therefore, as long as Changhua Pharmaceutical does not make any mistakes or any negative news appears, these reports will be the best advertising without Changhua Pharmaceutical spending a penny.

Therefore, there should be no problem with the sales of Joint Spirit in China.

As for sales abroad, there are agents doing promotions, so Changhua Pharmaceutical naturally doesn't have to worry about it. Agents will naturally handle these matters in order to obtain greater benefits for themselves.

Therefore, the sales of joint spirit today will definitely not be bad.

Li Changhua took out a report,

After placing it in front of Su Zhe, he said: "This is the latest production plan, which was implemented two days ago."

Su Zhe didn't say anything. He picked up the production report and read it.

Prior to this, the daily output of Thalysin and other drugs was maintained at 11 million tablets. Five million of them were provided to the Liu Group for sale in the domestic market. The other six million pieces are provided to foreign agents for sale.

But now that several new cooperative agents have been added, the output of the drug will naturally increase accordingly.

Therefore, the output of each drug has been increased, and it has also doubled. Now, except for Jie Ling, the daily output of several other drugs is 22 million tablets, including Jie Ling, which was just launched today. in this way.

Although Joint Spirit has just been launched, the sales volume should not be that high, but the market demand for Joint Spirit is very large, and the sales volume will soon increase to the same as that of blue elixir and other drugs.

Therefore, the current output of Joint Spirit is the same as that of blue elixir and other drugs, with a daily output of 22 million tablets.

However, the daily output of Thalysin has not increased so much. Because ALS is a very rare disease, the market demand is limited, so the domestic output has been reduced to four million pills, and the total The daily output is 18 million tablets, which is 4 million tablets less than other drugs.

If we do not continue to develop foreign markets, perhaps the sales volume of Thawling Ling will need to be controlled again.

Of course, this won't happen until a long time later, so you don't need to think too much about it now.

Except for 5 million tablets of each drug, which are reserved for the country, the remaining drugs are provided to agents in other countries.

Because as the production of medicines directly doubles, the monthly consumption of healing potions will also increase rapidly.

According to the current production plan, Changhua Pharmaceutical consumes at least 310 barrels of healing potions every month, and they are all high-concentration healing potions.

But fortunately, Su Zhe now provides more and more healing potions, so it can still meet the consumption.

Today alone, he sent 700 barrels of healing potion, which can meet the production needs for at least two months, so there is no need to worry about this.

Therefore, Su Zhe had no objection to Li Changhua's new production plan and directly agreed.

As for the pricing issue of Joint Spirit, it has been resolved in the previous meeting.

The production cost of a single piece of Joint Spirit is four yuan, which includes the cost of healing potions and other raw materials, as well as taxes, labor costs and other costs.

In addition, because Joint Spirit and Blue Elixir are the same, Su Zhe needs to pay an extra one yuan for each tablet sold. This is compensation for him to come up with the formula. This yuan is also included in the cost.

The ex-factory price of Joint Spirit is five yuan. Each piece of Joint Spirit brings a net profit of one yuan to Changhua Pharmaceutical, and the final retail price is six yuan.

But this is a domestic price, and foreign prices are not the same.

The ex-factory price of the drugs provided to foreign agents will be increased by 50%, which is 7.5 yuan. Every piece of joint spirit sold can bring a net profit of 3.5 yuan to Changhua Pharmaceutical.

As for the retail price abroad, it is determined by the agents themselves.

Of course, for foreign retail prices, the profit cannot exceed 20%. This is also stated in the agency agreement, and the agents have agreed.

Therefore, no matter how high the retail price abroad is, it will not be much higher and will still be within a reasonable range.

Su Zhe is not worried about this. After all, there is an agreement in advance, and he is not worried that foreign agents will act randomly and make crazy profits.

After Li Changhua talked about the medicine, he talked about the payment for the therapeutic potion: "From the 15th of last month to yesterday, the factory has consumed a total of 90 barrels of therapeutic potion, worth 3.6 billion yuan. The payment will be transferred to your account in a few days."

This is what Su Zhe and Li Changhua had agreed before. Changhua Pharmaceutical would pay as much as the therapeutic potion it uses every month.

As for the remaining treatment potions, they should be regarded as the reserves of Changhua Pharmaceutical and will be used later.

So, when Su Zhe heard this, he just nodded and said nothing. (To be continued...)

... ()